Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Hits & Misses
    • Artificial Intelligence and Healthcare
    • Doctors & Hospitals
      • COVID-19 and Public Health
    • Policy & Legislation
      • Affordable Care Act
    • Health Economics & Costs
      • Cost of Healthcare
      • Drug Prices & Regulations
      • Health Reform
    • Health Insurance
      • Public Insurance
      • Medicare
    • Telemedicine
      • Medical Tourism
  • Goodman Institute
  • Contact
  • Search
The Goodman Institute Health Blog

Author: Devon Herrick

Hearing Loss (and Poverty) Correlated with Dementia

Posted on January 8, 2024 by Devon Herrick

A cohort study of 573,088 people from Southern Denmark found an increased risk of dementia in those who experience hearing loss.

+

Drug Reimportation Approved in Florida (but it’s unlikely to work)

Posted on January 6, 2024 by Devon Herrick

The United States has a robust drug industry and Americans have access to a wide range of prescription drugs. However, drug prices are far higher in the U.S. than many other countries. The U.S. drug pipeline operates on what economists call price discrimination, charging some customers (countries) more than others.

+

WSJ: Wearing Socks to Bed is Not Crazy. Just a Way to Sleep Better

Posted on January 5, 2024 by Devon Herrick

My wife wears socks to bed because her feet get cold at night. I never wear socks to bed because my feet rarely feel cold. Plus, I do not like the feeling of something tight around my feet. Socks also grip the sheets and tug on them when I roll over. I never really thought wearing socks to bed was anything more than a personal choice by people with different attitudes about comfort while sleeping.

+

Do Drug Company Donations Buy Influence? Probably

Posted on January 2, 2024 by Devon Herrick

In the Summer of 2021 I wrote about a controversial new drug for Alzheimer’s Disease. The drug, Aduhelm, did not have a lot of evidence showing it worked. It did have plenty of data showing it came with an extensive list of nasty side effects, including brain swelling and brain bleeds. The U.S. Food and Drug Administration (FDA) approved it despite the agency’s advisory panel of experts recommending against it. The decision was controversial, and several members of the advisory panel resigned in protest.

+
  • Previous
  • 1
  • …
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • …
  • 214
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 44 other subscribers

Popular Topics

©2026 The Goodman Institute Health Blog | Website by Lexicom